Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su-Yun Wang

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|May 17, 2005
[Efficacy of shenqi fuzheng injection combined with chemotherapy in treatment of acute leukemia and its effect on T-lymphocyte subsets, serum IFN-gamma, IL-10 and IL-2]Ying-Fei Wei, Su-Yun Wang, Li-Li Ren
Zhonghua Nei Ke Za Zhi|January 6, 2005
[The relationship between beta fibrinogen gene-455G/A polymorphisms and Budd-Chiari syndrome]Su-yun Wang, Ying-fei Wei, Jing-dong Li
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|May 27, 2003
[Study on efficacy of treatment of acute leukemia by shengfu injection in combination with chemotherapy and the effect on cellular immunity, serum interleukin-6 and tumor necrosis factor-alpha levels]Ying-fei Wei, Hui-lan Du, Su-yun Wang
Risk Management and Healthcare Policy|October 1, 2025
A Quasi-Experimental Study on the Preventive Effect of Risk-Stratified Nursing Interventions for PICC-Related Thrombosis in Cancer PatientsChun-Jie Sun, Li Ma, Su-Yun Wang, et al.
Cell Insight|May 16, 2023
Mex3B inhibits DC-STAMP mRNA level and osteoclastogenesisYan Yang, Su-Yun Wang, Zhen-Qi Li, et al.
Indian Journal of Cancer|August 12, 2021
<i>JAK2</i> V617F mutation to calreticulin mutation in an essential thrombocythemia patient: A case reportSu-Yun Wang, Ning Yang, Li-Jun Zhang, et al.
Clinical Laboratory|February 14, 2023
Effects of Ruxolitinib on Myeloproliferative Neoplasms via the Negative RegulatorsSu-Yun Wang, Xu-Lei Xie, Jia-Yi Liang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 22, 2010
[Antioncogene PTEN-a new target for myeloma therapy]Su-Yun Wang, Zhi-Yong Cheng, Kai Deng, et al.
Leukemia & Lymphoma|May 31, 2017
Angiogenesis in JAK2 V617F positive myeloproliferative neoplasms and ruxolitinib decrease VEGF, HIF-1 enesis in JAK2 V617F positive cellsZhiyong Cheng, Jianzhu Fu, Guimin Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 15, 2024
Activation of the cGAS-STING-IRF3 Axis by Type I and II Interferons Contributes to Host DefenseZhen Tong, Jia-Peng Zou, Su-Yun Wang, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|May 17, 2005
[Efficacy of shenqi fuzheng injection combined with chemotherapy in treatment of acute leukemia and its effect on T-lymphocyte subsets, serum IFN-gamma, IL-10 and IL-2]Ying-Fei Wei, Su-Yun Wang, Li-Li Ren
Zhonghua Nei Ke Za Zhi|January 6, 2005
[The relationship between beta fibrinogen gene-455G/A polymorphisms and Budd-Chiari syndrome]Su-yun Wang, Ying-fei Wei, Jing-dong Li
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|May 27, 2003
[Study on efficacy of treatment of acute leukemia by shengfu injection in combination with chemotherapy and the effect on cellular immunity, serum interleukin-6 and tumor necrosis factor-alpha levels]Ying-fei Wei, Hui-lan Du, Su-yun Wang
Risk Management and Healthcare Policy|October 1, 2025
A Quasi-Experimental Study on the Preventive Effect of Risk-Stratified Nursing Interventions for PICC-Related Thrombosis in Cancer PatientsChun-Jie Sun, Li Ma, Su-Yun Wang, et al.
Cell Insight|May 16, 2023
Mex3B inhibits DC-STAMP mRNA level and osteoclastogenesisYan Yang, Su-Yun Wang, Zhen-Qi Li, et al.
Indian Journal of Cancer|August 12, 2021
<i>JAK2</i> V617F mutation to calreticulin mutation in an essential thrombocythemia patient: A case reportSu-Yun Wang, Ning Yang, Li-Jun Zhang, et al.
Clinical Laboratory|February 14, 2023
Effects of Ruxolitinib on Myeloproliferative Neoplasms via the Negative RegulatorsSu-Yun Wang, Xu-Lei Xie, Jia-Yi Liang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 22, 2010
[Antioncogene PTEN-a new target for myeloma therapy]Su-Yun Wang, Zhi-Yong Cheng, Kai Deng, et al.
Leukemia & Lymphoma|May 31, 2017
Angiogenesis in JAK2 V617F positive myeloproliferative neoplasms and ruxolitinib decrease VEGF, HIF-1 enesis in JAK2 V617F positive cellsZhiyong Cheng, Jianzhu Fu, Guimin Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 15, 2024
Activation of the cGAS-STING-IRF3 Axis by Type I and II Interferons Contributes to Host DefenseZhen Tong, Jia-Peng Zou, Su-Yun Wang, et al.
Pageof 6